CAS 83602-41-9
:(1R,2R,4E)-1-[(2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,10,16,20,23,25,26,31-nonamethyl-14,32-bis(1-methylethyl)-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacont
Description:
The chemical substance with the name "(1R,2R,4E)-1-[(2S,5S,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,10,16,20,23,25,26,31-nonamethyl-14,32-bis(1-methylethyl)-11,17,26,29-tetrakis(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-1,4,7,10,13,16,19,22,25,28,31-undecaazacyclotritriacont" and CAS number "83602-41-9" is a complex organic compound characterized by its intricate structure, which includes multiple chiral centers and a significant number of functional groups. This substance likely exhibits a high molecular weight due to its extensive carbon backbone and numerous substituents, contributing to its potential biological activity. The presence of multiple oxo groups suggests it may have applications in medicinal chemistry or materials science. Additionally, the stereochemistry indicated by the R and S designations implies that the compound may exhibit specific interactions with biological targets, making it of interest in pharmacology. Its solubility, stability, and reactivity would depend on the specific functional groups and overall molecular architecture, which could influence its behavior in various chemical environments.
Formula:C64H113N11O13
InChI:InChI=1/C64H113N11O13/c1-26-28-29-41(15)53(88-44(18)76)52-57(81)67-45(27-2)59(83)70(20)34-49(77)71(21)47(31-36(5)6)56(80)69-50(39(11)12)61(85)72(22)48(32-37(7)8)55(79)65-42(16)54(78)66-43(17)58(82)75(25)64(19,33-38(9)10)63(87)68-46(30-35(3)4)60(84)73(23)51(40(13)14)62(86)74(52)24/h26,28,35-43,45-48,50-53H,27,29-34H2,1-25H3,(H,65,79)(H,66,78)(H,67,81)(H,68,87)(H,69,80)/b28-26+/t41-,42+,43-,45+,46+,47+,48+,50+,51+,52+,53-,64+/m1/s1
Synonyms:- o-Acetyl C(9) cyclosporin a
- Cyclosporin A, 6-[(2S,3R,4R,6E)-3-(acetyloxy)-4-methyl-2-(methylamino)-6-octenoic acid]-
- (3R,4R)-3-Acetoxy-N-methyl-5-[(E)-1-propenyl]-cyclo(L-Leu-L-Abu-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-)
- Cyclosporin A Acetate
- Aids097134
- (3R,4R)-3-Acetoxy-N-methyl-5-[(E)-1-propenyl]cyclo(L-Leu-L-Abu-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-)
- SDZ 33-243
- Sdz 033-243
- Cyclosporin A O-Acetyl Impurity
- (3R,4R)-N-Methyl-3-acetoxy-5-[(E)-1-propenyl]-cyclo(L-Leu-L-Abu-Sar-N-methyl-L-Leu-L-Val-N-methyl-L-Leu-L-Ala-D-Ala-N-methyl-L-Leu-N-methyl-L-Leu-N-methyl-L-Val-)
- O-Acetylcyclosporin A
- Cyclosporine A acetate
- 6-[(2S,3R,4R,6E)-3-(Acetyloxy)-4-Methyl-2-(MethylaMino)-6-octenoic acid] Cyclosporin A
- Acetylcyclosporin A
- B-3-243
- Aids-097134
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Cyclosporin A-13C2,d4 Acetate
CAS:Controlled Product<p>Applications Labelled Cyclosporin A (C988901) derivative. An immunosuppressant that has revolutionized organ transplantation through its use in the prevention of graft rejection.A group of nonpolar cyclic oligopeptides with immunosupppressant activity.<br>References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005)<br></p>Formula:C62C2H109D4N11O13Color and Shape:NeatMolecular weight:1250.65Cyclosporin A-d4 Acetate (Major)
CAS:Controlled Product<p>Applications A non-immunosuppressive analog of Cyclosporin A.<br>References Twentyman, P. R., et al.: Brit. J. Cancer, 57, 254 (1988), Twentyman, P. R., et al.: Brit. J. Cancer, 65, 335 (1992), Schneider, H., et al.: Biochem., 33, 8218 (1994).<br></p>Formula:C64H109D4N11O13Color and Shape:NeatMolecular weight:1248.67Cyclosporin A acetate
CAS:<p>Cyclosporin A is a cyclic non-hydrolyzable glycol ester that inhibits the production of cytokines and inflammatory mediators by binding to specific intracellular receptors. Cyclosporin A acetate is an inactive prodrug that is converted to active cyclosporine in the liver. Cyclosporin A acetate has been shown to be effective in treating autoimmune diseases such as rheumatoid arthritis and psoriasis, as well as atopic dermatitis. Cyclosporin A acetate is used orally and usually taken with food or milk to reduce gastrointestinal irritation. The oral dosage form of this drug contains saccharose as a diluent and surfactant, which reduces the risk of gastrointestinal irritation.</p>Formula:C64H113N11O13Purity:(%) Min. 95%Color and Shape:PowderMolecular weight:1,244.65 g/mol



